Changing Cancer Research
Diane discusses her journey in pancreatic cancer research, highlighting the need for collaboration among institutions to tackle complex challenges. The new adaptive platform trial, Precision Promise, aims to revolutionize how clinical trials are conducted by emphasizing data sharing and teamwork. With the support of a nonprofit advocacy group, this initiative is already enrolling patients across multiple hospitals, marking a significant shift in the fight against pancreatic cancer.In this clip
From this podcast
Freakonomics Radio
How to Fix the Incentives in Cancer Research | Freakonomics Radio | Episode 449
Related Questions